Canadian patients and groups representing them are sounding the alarm about recent changes made by the federal government to the way it regulates the cost of patented medicines. Shelves of medication are seen at a pharmacy in Quebec City, Thursday, March 8, 2012. THE CANADIAN PRESS/Jacques Boissinot